Agenus Inc.

US$7.15As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:AGENHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (21.21%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 1.52
PE TTM 16.63
TSR TTM 80.10%
Mkt cap US$323.5M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$7.77
8.63%
(42.37%)
Hold 11|6|2|6|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.16
0.17
0.18
0.18
26.14%
34.50%
31.61%
21.81%
Revenue$M
27.26
27.40
28.93
30.32
1.68%
0.80%
8.94%
17.51%
Peers (US$323.5M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.552
1.677
1.538
EBIT/Intx
1.126
0.092
0.095
Own earn%
5.75
(63.80)
(41.09)
Sh yield%
16.25
35.34
38.18
Owners
Insiders/Inst%
13.33
34.89
Short interest%
2.27
SBC / revenue%
5.80
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
9–19
$1 testx
—
Incr. ROIC%
1